Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with endometrial cancer confirmed through laboratory testing of tissue samples
- People whose cancer appears to be at an early stage (Stage I or II) based on assessments done before surgery
- People who are planned to undergo full surgical treatment to remove the cancer
- People who are planned to have a sentinel lymph node mapping procedure attempted during surgery (a technique to check nearby lymph nodes for cancer spread)
Who may not be able to join:
- People whose cancer is a type called uterine sarcoma, including a subtype known as endometrial stromal sarcoma
- People who are having surgery that aims to preserve the ability to have children in the future
- People whose cancer is classified as a "dedifferentiated" type (confirm with trial site)
- People whose cancer is classified as an "undifferentiated" type (confirm with trial site)
- People who have received treatment such as chemotherapy or radiation before surgery
- People who have had previous surgery involving the lymph nodes in the pelvic area
- People whose lymph nodes appear enlarged (greater than 15mm on the short side) on pre-surgery scans
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Francesco Fanfani, Professor, Fondazione Policlinico Agostino Gemelli IRCCS
Phone: +390630153421
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of SLN metastasis detected by OSNA versus ultrastaging method
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.